The culture and identification of human placenta-derived mesenchymal stem cells
New Cell · 2024
DOI: 10.61958/nclg8527 ↗Kurz gefasst
Fachartikel in der Zeitschrift New Cell, 2024. Verfasst von Ruo-Lan Du und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Objective
This study aimed to establish a reliable protocol for the cultivation and characterization of human placenta-derived mesenchymal stem cells (hPMSCs) to evaluate their growth dynamics and immunophenotype. Methods: hPMSCs were thawed and cultured under controlled conditions using specialized serum-free medium. Cell viability and morphology were assessed using an inverted microscope, and medium changes were performed bi-daily. For cell identification, immunofluorescence staining was conducted with antibodies CD44, CD90, and CD45, and cells were characterized based on surface marker expression.
Results
Cultured hPMSCs exhibited a fibroblast-like morphology with rapid proliferation, particularly after reaching a seeding density of 50%. Growth curves indicated peak proliferation between days 3 and 4. Immunofluorescence analysis confirmed that hPMSCs were positive for CD90 and CD44, but negative for CD45, aligning with typical mesenchymal stem cell profiles.
Conclusion
The established protocol successfully cultivated and characterized hPMSCs, demonstrating their viability and specific surface markers. These findings support their potential application in regenerative medicine and therapeutic research.
Zitieren
APA
Du, R., & Wang, T. (2024). The culture and identification of human placenta-derived mesenchymal stem cells. New Cell. https://doi.org/10.61958/nclg8527
Vancouver
Du R, Wang T. The culture and identification of human placenta-derived mesenchymal stem cells. New Cell. 2024. doi:10.61958/nclg8527
BibTeX
@article{Du2024,
author = {Du, Ruo-Lan and Wang, Ting-Hua},
title = {The culture and identification of human placenta-derived mesenchymal stem cells},
journal = {New Cell},
year = {2024},
doi = {10.61958/nclg8527}
}
EUVIMED